Cleveland Clinic Abu Dhabi has appointed Peng Xiao, Group CEO of G42 and member of the Artificial Intelligence and Advanced Technology Council (AIATC), as Chairman of its Board of Directors. The move signals the hospital’s next phase of growth, focused on harnessing artificial intelligence and precision medicine to elevate complex-care outcomes.
Peng Xiao is a distinguished global technology leader who has steered G42 to the forefront of artificial intelligence and advanced technology. His appointment underscores Cleveland Clinic Abu Dhabi’s commitment to harnessing breakthrough innovations—such as AI-driven diagnostics and precision medicine—to improve patient outcomes and cement Abu Dhabi’s status as a global hub for healthcare advancement.
Peng Xiao, Chairman of the Board of Directors of Cleveland Clinic Abu Dhabi, said: “It is an honor to chair Cleveland Clinic Abu Dhabi. By combining the hospital’s renowned clinical expertise with advanced artificial intelligence, we will deliver earlier diagnoses, more precise therapies, and better outcomes for every patient. Nowhere is this vision more achievable than in Abu Dhabi, where forward-looking national leadership is committed to deploying technology that advances healthcare—not only for our region, but for humanity as a whole.”
Established in 2015 to help realize Abu Dhabi’s vision for a world-class healthcare ecosystem, Cleveland Clinic Abu Dhabi is an extension of the renowned Cleveland Clinic model of care. With over one million patients served, Cleveland Clinic Abu Dhabi has introduced numerous clinical firsts, significantly reduced the need for outbound medical travel, and grown into a recognized leader in healthcare transformation.
Dr. Tom Mihaljevic, CEO and President of Cleveland Clinic and Morton L. Mandel CEO Chair, commented: “Cleveland Clinic Abu Dhabi exemplifies our mission to deliver compassionate, patient-centered care worldwide. We are proud of the hospital’s remarkable achievements over the past 10 years and are confident that under Peng Xiao’s leadership, it will continue to grow as a beacon of excellence and innovation in the region.”
Dr. Georges-Pascal Haber, CEO of Cleveland Clinic Abu Dhabi, added: “Under Peng Xiao’s visionary leadership, Cleveland Clinic Abu Dhabi will continue to redefine the future of healthcare by integrating cutting-edge technologies with world-class clinical expertise. As a catalyst for transformative innovation, the hospital will accelerate breakthroughs in precision medicine, artificial intelligence, and digital health—elevating Abu Dhabi’s standing as a global epicenter for healthcare excellence and next-generation care.”
The transition follows the tenure of Hasan Jasem Al Nowais, whose leadership as Chairman was instrumental in shaping the hospital’s recent success. Cleveland Clinic Abu Dhabi thanks him for his contributions.
Having just celebrated its 10th anniversary, the hospital remains a regional leader in healthcare delivery, education, and research. It has earned multiple international accolades and was recently ranked the top hospital in both the UAE and the GCC in Newsweek’s 2025 “World’s Best Hospitals” list.
Cleveland Clinic Abu Dhabi, part of the M42 network, has become one of the UAE’s pioneering healthcare organisations to receive Provisional Accreditation from the Accreditation Council for Continuing Medical Education (ACCME®). The accreditation acknowledges the hospital as a distinguished provider of Continuing Medical Education (CME), further empowering the institution to grant credits for local, regional, and international medical education programs, including the American Medical Association (AMA) Physician’s Recognition Award (PRA) Category 1 Credit™.
Dr. Jorge Guzman, Chief Executive Officer of Cleveland Clinic Abu Dhabi, expressed his gratitude, stating, “This groundbreaking achievement is a testament to our steadfast commitment to excellence in medical education and healthcare delivery. With this milestone accreditation, Cleveland Clinic Abu Dhabi has set its sight on attracting a global audience of medical education facilitators, organizers, and decision-makers, as we continue to set new benchmarks and raise the bar, ensuring that the UAE remains at the forefront of medical innovation and expertise. We will continue to focus on upskilling of local and global talent to strengthen UAE’s positioning as a medical education hub.”
The ACCME accreditation reinforces the commitment of CME providers to ensure that medical education remains fair, balanced, evidence-based, valid, relevant to clinicians’ needs, evaluated for its effectiveness, and free from any commercial influence. By achieving this designation, Cleveland Clinic Abu Dhabi strengthens its mission to ‘educate those who serve’ and solidifies its role in advancing medical knowledge with the highest standards of integrity.
Dr. Sawsan Abdel-Razig, Chief Academic Officer at Cleveland Clinic Abu Dhabi, commented, “We are truly honored to be recognized as a leading ACCME-accredited organization in the UAE. Our Education Department designs robust, competency-based education and professional development programs that provide world-class healthcare education to current and future healthcare providers. This achievement further enhances Cleveland Clinic Abu Dhabi’s reputation and its ability to build a sustainable healthcare sector in the UAE.”
Cleveland Clinic Abu Dhabi’s recognition as the principal organization to be awarded the Provisional Accreditation by ACCME complements the existing CME accreditation system led by the local UAE accreditation bodies and does not aim to replace it. To find out more about the Provisional Accreditation from the Accreditation Council for Continuing Medical Education (ACCME®) visit the website https://www.accme.org/
To book an appointment at Cleveland Clinic Abu Dhabi, call 800 8 CCAD (2223) visit www.clevelandclinicabudhabi.ae or download the Cleveland Clinic Abu Dhabi Patient Portal App.